Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service DBS & VNS cases in Texas: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 17% on average (103 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 16 | 972 | 44% |
| 2020 | 11 | 755 | 47% |
| 2021 | 13 | 982 | 51% |
| 2022 | 13 | 801 | 54% |
| 2023 | 14 | 909 | 57% |
| 2024 | 18 | 941 | 59% |
| 2025 from claims | – | 1,177 951–1,382 | 59% |
| 2026 forecast | – | 1,229 963–1,544 | 60% |
| 2027 forecast | – | 1,283 952–1,697 | 60% |
| 2028 forecast | – | 1,340 948–1,849 | 61% |
| 2029 forecast | – | 1,398 950–2,004 | 61% |
| 2030 forecast | – | 1,459 956–2,165 | 62% |
Deep brain and vagus nerve stimulator implants. Professional codes (what the surgeon bills): CPT 61863, 61867, 61885, 61886, 64568; the hospital bills MS-DRG 040, 041, 042.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 83% of the cases CMS names in Texas; 10 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 30% inpatient hospital, 68% hospital outpatient, 2% surgery center.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Florida | 13 | 844+0.5%/yr | +0.5%/yr | 0.4 | 2% | 1,550 in 2030+11%/yr |
| North Carolina | 8 | 293−8.9%/yr | −8.9%/yr | 0.3 | 0% | 440 in 2030+7.1%/yr |
| Virginia | 5 | 275−0.4%/yr | −0.4%/yr | 0.3 | 0% | 420 in 2030+7.4%/yr |
| Tennessee | 4 | 252+1%/yr | +1%/yr | 0.3 | 0% | 270 in 2030+1.2%/yr |
| Georgia | 3 | 211+0.2%/yr | +0.2%/yr | 0.2 | 0% | 230 in 2030+1.1%/yr |
| Kentucky | 5 | 203−3.5%/yr | −3.5%/yr | 0.4 | 0% | 330 in 2030+8.4%/yr |
| Alabama | 4 | 187−6.5%/yr | −6.5%/yr | 0.4 | 0% | 190 in 2030+0.5%/yr |
| Oklahoma | 3 | 152+4.2%/yr | +4.2%/yr | 0.3 | 0% | 150 in 2030−0.1%/yr |
| South Carolina | 2 | 151−3.2%/yr | −3.2%/yr | 0.2 | 0% | 260 in 2030+9.8%/yr |
| Louisiana | 2 | 151−6.2%/yr | −6.2%/yr | 0.4 | 0% | 1,100 in 2030+39%/yr |
| Maryland | 1 | 111−4.1%/yr | −4.1%/yr | 0.1 | 0% | 120 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 28 | 1,099+13%/yr | +13%/yr | 0.51.2× | 0% | 2,130 in 2030+12%/yr |
| Stroke thrombectomy | 25 | 822−0.1%/yr | −0.1%/yr | 0.40.9× | 0% | 1,230 in 2030+6.9%/yr |
| CSF shunts | 2 | 476−4.6%/yr | −4.6%/yr | 0.21.2× | 0% | 540 in 2030+2.2%/yr |
DBS & VNS in every state, and its device makers · Every procedure market in Texas · Every state · Compare with Florida
Livanova leads with 51% of company spending on these surgeons in 2025, +8 pts on 2024.
In 2025, 7 companies reported engagement with Texas’s surgeons worth $668K in consulting, speaking, meals and travel tied to these products, about $37K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 56 clearances and approvals in the category, 2 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.